Merck
MRK
$129.83
Share price
2.23%
Change (1 day)
11.98%
Change (1 year)
Categories
Merck (MRK) - Cash on Hand
Cash on Hand as of December 2023 : $7.09 B
According to Merck's latest financial reports the company has $7.09 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Merck - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $7.09 B | -46.23% |
| 2022-12-31 | $13.19 B | 62.94% |
| 2021-12-31 | $8.09 B | 0.57% |
| 2020-12-31 | $8.05 B | -22.97% |
| 2019-12-31 | $10.45 B | 17.89% |
| 2018-12-31 | $8.86 B | 4.31% |
| 2017-12-31 | $8.49 B | -40.74% |
| 2016-12-31 | $14.34 B | 6.81% |
| 2015-12-31 | $13.42 B | -14.58% |
| 2014-12-31 | $15.71 B | -10.11% |
| 2013-12-31 | $17.48 B | 8.33% |
| 2012-12-31 | $16.14 B | 7.81% |
| 2011-12-31 | $14.97 B | 22.71% |
| 2010-12-31 | $12.20 B | 27.04% |
| 2009-12-31 | $9.60 B | 75.05% |
| 2008-12-31 | $5.48 B | -33.34% |
| 2007-12-31 | $8.23 B | -5.53% |
| 2006-12-31 | $8.71 B | -44.28% |
| 2005-12-31 | $15.63 B | 120.56% |
| 2004-12-31 | $7.08 B | 69.9% |
| 2003-12-31 | $4.17 B | -16.06% |
| 2002-12-31 | $4.97 B | 51.26% |
| 2001-12-31 | $3.28 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 223.23% | 🇺🇸 USA |
 Novartis NVS | $13.96 B | 96.84% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 78.91% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | 2.62% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | -58.72% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 54.29% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 39.97% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $12.28 B | 73.13% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | -10.41% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $3.22 B | -54.52% | 🇮🇱 Israel |